Literature DB >> 8102296

Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis.

A Blumenfeld1, S A Slaugenhaupt, F B Axelrod, D E Lucente, C Maayan, C B Liebert, L J Ozelius, J A Trofatter, J L Haines, X O Breakefield.   

Abstract

Familial dysautonomia (DYS), the Riley-Day syndrome, is an autosomal recessive disorder characterized by developmental loss of neurons from the sensory and autonomic nervous system. It is limited to the Ashkenazi Jewish population, where the carrier frequency is 1 in 30. We have mapped the DYS gene to chromosome 9q31-q33 by linkage with ten DNA markers in 26 families. The maximum lod score of 21.1 with no recombinants was achieved with D9S58. This marker also showed strong linkage disequilibrium with DYS, with one allele present on 73% of affected chromosomes compared to 5.4% of controls (chi 2 = 3142, 15 d.f. p < 0.0001). D9S53 and D9S105 represent the closest flanking markers for the disease gene. This localization will permit prenatal diagnosis of DYS in affected families and aid the isolation of the disease gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102296     DOI: 10.1038/ng0693-160

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  31 in total

1.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

2.  Quantitative sensory testing of thermal and vibratory perception in familial dysautonomia.

Authors:  M J Hilz; F B Axelrod
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

3.  Can loss of muscle spindle afferents explain the ataxic gait in Riley-Day syndrome?

Authors:  Vaughan G Macefield; Lucy Norcliffe-Kaufmann; Joel Gutiérrez; Felicia B Axelrod; Horacio Kaufmann
Journal:  Brain       Date:  2011-11       Impact factor: 13.501

Review 4.  Cardiac pacing in patients with familial dysautonomia--there is nothing simple about sudden death.

Authors:  Angelo Bartoletti
Journal:  Clin Auton Res       Date:  2005-02       Impact factor: 4.435

5.  Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.

Authors:  Matthew M Hims; El Chérif Ibrahim; Maire Leyne; James Mull; Lijuan Liu; Conxi Lazaro; Ranjit S Shetty; Sandra Gill; James F Gusella; Robin Reed; Susan A Slaugenhaupt
Journal:  J Mol Med (Berl)       Date:  2007-01-06       Impact factor: 4.599

Review 6.  Familial dysautonomia (Riley-Day syndrome).

Authors:  A Shetty; P Parikh; R P Khubchandani
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

7.  Clinical neuro-ophthalmic findings in familial dysautonomia.

Authors:  Carlos E Mendoza-Santiesteban; Thomas R Hedges; Lucy Norcliffe-Kaufmann; Floyd Warren; Shantan Reddy; Felicia B Axelrod; Horacio Kaufmann
Journal:  J Neuroophthalmol       Date:  2012-03       Impact factor: 3.042

8.  The genetic clock and the age of the founder effect in growing populations: a lesson from French Canadians and Ashkenazim.

Authors:  D Labuda; E Zietkiewicz; M Labuda
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

9.  2016 William Allan Award: Human Disease Research: Genetic Cycling and Re-cycling.

Authors:  James F Gusella
Journal:  Am J Hum Genet       Date:  2017-03-02       Impact factor: 11.025

Review 10.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.